Valuation: Pharmaron Beijing Co., Ltd.

Capitalization 43.91B 6.05B 5.76B 5.44B 4.8B 8.58B 525B 9.52B 64.73B 23.98B 219B 22.7B 22.24B 921B P/E ratio 2024 *
26.3x
P/E ratio 2025 * 25.9x
Enterprise value 46.76B 6.45B 6.14B 5.79B 5.11B 9.13B 559B 10.14B 68.93B 25.54B 234B 24.17B 23.68B 980B EV / Sales 2024 *
3.82x
EV / Sales 2025 * 3.3x
Free-Float
-
Yield 2024 *
0.83%
Yield 2025 * 0.78%
More valuation ratios * Estimated data
Dynamic Chart
1 day-1.58%
1 week-1.42%
Current month+3.10%
1 month+4.96%
3 months-16.22%
6 months+22.53%
Current year-0.31%
More quotes
1 week
25.57
Extreme 25.57
26.89
1 month
24.62
Extreme 24.62
26.89
Current year
23.85
Extreme 23.85
26.89
1 year
17.70
Extreme 17.7
36.42
3 years
17.70
Extreme 17.7
76.09
5 years
17.70
Extreme 17.7
108.71
10 years
4.08
Extreme 4.0844
108.71
More quotes
Director TitleAgeSince
President 56 -
Corporate Officer/Principal 58 2016-10-26
Chief Executive Officer 61 2016-10-26
Manager TitleAgeSince
Chairman 61 2016-10-26
Director/Board Member 58 2016-10-26
Chairman 63 2016-10-26
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi.($)
-1.58%-1.42%+21.59%-45.35% 6.05B
-0.43%-1.39%+28.71%-1.26% 47.89B
-1.33%-7.06%-19.89%-15.40% 34.06B
-0.45%-1.71%-0.38%+22.57% 26.65B
+0.04%+6.58%+72.73%+81.40% 16.54B
+1.95%-3.75%-35.82%-23.17% 15.37B
+6.79%+29.70% - - 14.08B
+3.35%+1.20%-63.80%-78.17% 12.7B
-1.12%-9.44%-7.47%-36.10% 10.42B
-0.65%-3.93%-13.74%+144.96% 10.36B
Average +0.66%+0.85%-2.01%+5.50% 19.41B
Weighted average by Cap. +0.32%-0.01%+2.45%+4.81%
See all sector performances

Financials

2024 *2025 *
Net sales 12.25B 1.69B 1.61B 1.52B 1.34B 2.39B 146B 2.65B 18.05B 6.69B 61.17B 6.33B 6.2B 257B 14.09B 1.94B 1.85B 1.74B 1.54B 2.75B 168B 3.06B 20.77B 7.7B 70.39B 7.28B 7.14B 295B
Net income 1.88B 259M 246M 232M 205M 366M 22.4B 407M 2.76B 1.02B 9.37B 969M 950M 39.32B 1.87B 258M 246M 232M 205M 365M 22.34B 406M 2.76B 1.02B 9.34B 967M 947M 39.22B
Net Debt 2.85B 392M 374M 352M 311M 556M 34B 617M 4.2B 1.55B 14.22B 1.47B 1.44B 59.67B 2.62B 361M 344M 324M 286M 511M 31.26B 567M 3.86B 1.43B 13.07B 1.35B 1.33B 54.87B
More financial data * Estimated data
Logo Pharmaron Beijing Co., Ltd.
Pharmaron Beijing Co. is specialised in the research, development and manufacturing of small molecule drugs, cell therapies and gene therapies. Net sales break down by activity as follows: - laboratory services (61.3%); - development and production of chemical processes and formulations (23.5%); - clinical research services (12.8%); - other (2.4%); Net sales are distributed geographically as follows: China (17.1%), Asia (2.6%), North America (64.2%), Europe (15.6%) and other (0.5%).
Employees
20,295
More about the company
Date Price Change Volume
25-02-14 26.75 ¥ +4.41% 39,399,970
25-02-13 25.62 ¥ -1.58% 15,105,320
25-02-12 26.03 ¥ +0.58% 14,213,030
25-02-11 25.88 ¥ -3.32% 22,168,580
25-02-10 26.77 ¥ +1.94% 23,193,800

End-of-day quote Shenzhen S.E., February 12, 2025

More quotes
Trading Rating
Investor Rating
ESG MSCI
AA
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
26.75CNY
Average target price
28.46CNY
Spread / Average Target
+6.38%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. 300759 Stock